Introducing:

A new blood test for multiple cancers which can help identify the disease at an early, more treatable stage.

Get screened at one of the participating Urgent Cares

OneTest is powered by A.I. technology

OneTest can aid in the early detection of multiple cancers.

%

According to the American Cancer Society, a person’s lifetime risk of getting cancer is almost 40%

%

With lung cancer, survival rate for stage 1 cancer exceeds 90%

%

If lung cancer advances to form multiple, distant tumors, survival rates can fall to below 1%

Our mission is to help reduce cancer deaths around the world through early detection

 

OneTest is the first test of its kind to combine the results of multiple cancer biomarker tests and personal health data using an artificial intelligence algorithm to calculate a risk score for 6 or more types of cancer.

  • Built with a vast database of about 42,000 individuals
  • Easy & painless blood test
  • Powered and validated by real world data

Benefits of OneTest

The OneTest biomarkers aid in the early detection of many of the cancers that are not widely screened for in the USA.

OneTest can help in the detection of multiple cancers before symptoms occur, when treatments are more effective and less expensive.

Annual testing can detect subtle changes in cancer marker scores that may successfully lead to early diagnoses of developing cancers.

Get screened at one of the participating Urgent Cares

Lifeline Urgent Care

8507 Liberty Rd #L1 Randallstown, MD 21133

Phone: (410) 496-9105

Richmond Urgent Care 

1770 N Parham Rd #100, Richmond, VA 23229

Phone: (804) 615-5060

AFC Urgent Care Wichita

3161 N Rock Rd Suite A, Wichita, KS 67226

Phone: (316) 440-2535

Can't find a participating urgent care near you? You can order your OneTest online.

Testimonial

Dr. Ronald Shore talks about OneTest and the importance of early detection.

Ronald Shore M.D.

Dermatologist

Cancer Screening Advocate

20/20 GeneSystems developed OneTest for Cancer

• awarded more than $6 million in government grants and contracts from the National Institutes of Health (NIH) in support of cancer diagnostic technologies

• 7 issued patents with numerous patent applications pending worldwide

• raised over $7.5 million in private investments and an equivalent amount through numerous government and private grants